Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar;53(3):728-738.
doi: 10.1161/STROKEAHA.121.037541. Epub 2022 Feb 10.

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

Shadi Yaghi  1 Liqi Shu  1 Ekaterina Bakradze  2 Setareh Salehi Omran  3 James A Giles  4 Jordan Y Amar  4 Nils Henninger  5   6 Marwa Elnazeir  5 Ava L Liberman  7 Khadean Moncrieffe  8 Jenny Lu  8 Richa Sharma  9 Yee Cheng  9 Adeel S Zubair  9 Alexis N Simpkins  10 Grace T Li  10 Justin Chi Kung  10 Dezaray Perez  10 Mirjam Heldner  11 Adrian Scutelnic  11 David Seiffge  11 Bernhard Siepen  11 Aaron Rothstein  12 Ossama Khazaal  12 David Do  12 Sami Al Kasab  13   14 Line Abdul Rahman  13 Eva A Mistry  15 Deborah Kerrigan  16 Hayden Lafever  16 Thanh N Nguyen  17 Piers Klein  15   17 Hugo Aparicio  17 Jennifer Frontera  18 Lindsey Kuohn  18 Shashank Agarwal  18 Christoph Stretz  1 Narendra Kala  1 Sleiman El Jamal  1 Alison Chang  1 Shawna Cutting  1 Han Xiao  19 Adam de Havenon  9 Varsha Muddasani  20 Teddy Wu  21 Duncan Wilson  21 Amre Nouh  22 Syed Daniyal Asad  22 Abid Qureshi  23 Justin Moore  23 Pooja KhatriYasmin Aziz  15 Bryce Casteigne  15 Muhib Khan  24 Yao Cheng  24 Brian Mac Grory  25 Martin Weiss  25 Dylan Ryan  25 Maria Cristina Vedovati  26 Maurizio Paciaroni  27 James E Siegler  28 Scott Kamen  28 Siyuan Yu  28 Christopher R Leon Guerrero  29 Eugenie Atallah  29 Gian Marco De Marchis  30 Alex Brehm  31 Tolga Dittrich  30 Marios Psychogios  31 Ronald Alvarado-Dyer  32 Tareq Kass-Hout  32 Shyam Prabhakaran  32 Tristan Honda  33 David S Liebeskind  33 Karen Furie  1
Affiliations
Free article
Randomized Controlled Trial

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

Shadi Yaghi et al. Stroke. 2022 Mar.
Free article

Abstract

Background: A small randomized controlled trial suggested that dabigatran may be as effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to compare direct oral anticoagulants (DOACs) to warfarin in a real-world CVT cohort.

Methods: This multicenter international retrospective study (United States, Europe, New Zealand) included consecutive patients with CVT treated with oral anticoagulation from January 2015 to December 2020. We abstracted demographics and CVT risk factors, hypercoagulable labs, baseline imaging data, and clinical and radiological outcomes from medical records. We used adjusted inverse probability of treatment weighted Cox-regression models to compare recurrent cerebral or systemic venous thrombosis, death, and major hemorrhage in patients treated with warfarin versus DOACs. We performed adjusted inverse probability of treatment weighted logistic regression to compare recanalization rates on follow-up imaging across the 2 treatments groups.

Results: Among 1025 CVT patients across 27 centers, 845 patients met our inclusion criteria. Mean age was 44.8 years, 64.7% were women; 33.0% received DOAC only, 51.8% received warfarin only, and 15.1% received both treatments at different times. During a median follow-up of 345 (interquartile range, 140-720) days, there were 5.68 recurrent venous thrombosis, 3.77 major hemorrhages, and 1.84 deaths per 100 patient-years. Among 525 patients who met recanalization analysis inclusion criteria, 36.6% had complete, 48.2% had partial, and 15.2% had no recanalization. When compared with warfarin, DOAC treatment was associated with similar risk of recurrent venous thrombosis (aHR, 0.94 [95% CI, 0.51-1.73]; P=0.84), death (aHR, 0.78 [95% CI, 0.22-2.76]; P=0.70), and rate of partial/complete recanalization (aOR, 0.92 [95% CI, 0.48-1.73]; P=0.79), but a lower risk of major hemorrhage (aHR, 0.35 [95% CI, 0.15-0.82]; P=0.02).

Conclusions: In patients with CVT, treatment with DOACs was associated with similar clinical and radiographic outcomes and favorable safety profile when compared with warfarin treatment. Our findings need confirmation by large prospective or randomized studies.

Keywords: anticoagulants; contraindications; dabigatran; hemorrhage; venous thrombosis.

PubMed Disclaimer

Comment in

  • ACTION-CVT: Are the Findings ACTIONable?
    Gorman JB, Field TS. Gorman JB, et al. Stroke. 2022 Mar;53(3):739-741. doi: 10.1161/STROKEAHA.122.038564. Epub 2022 Feb 10. Stroke. 2022. PMID: 35143324 No abstract available.

Similar articles

Cited by

  • Direct oral anticoagulants for treatment of venous thrombosis: illustrated review of appropriate use.
    Khairani CD, Bejjani A, Assi A, Porio N, Talasaz AH, Piazza G, Cushman M, Bikdeli B. Khairani CD, et al. Res Pract Thromb Haemost. 2024 Apr 26;8(4):102424. doi: 10.1016/j.rpth.2024.102424. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38812988 Free PMC article.
  • Functional outcome predictors and recanalization in cerebral venous thrombosis: A single-center cross-sectional study.
    Shahid R, Zafar A. Shahid R, et al. Turk J Emerg Med. 2024 Oct 1;24(4):218-225. doi: 10.4103/tjem.tjem_65_24. eCollection 2024 Oct-Dec. Turk J Emerg Med. 2024. PMID: 39564436 Free PMC article.
  • Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.
    Nguyen TN, Qureshi MM, Klein P, Yamagami H, Abdalkader M, Mikulik R, Sathya A, Mansour OY, Czlonkowska A, Lo H, Field TS, Charidimou A, Banerjee S, Yaghi S, Siegler JE, Sedova P, Kwan J, de Sousa DA, Demeestere J, Inoa V, Omran SS, Zhang L, Michel P, Strambo D, Marto JP, Nogueira RG; SVIN COVID-19 Global COVID Stroke Registry; Kristoffersen ES, Tsivgoulis G, Lereis VP, Ma A, Enzinger C, Gattringer T, Rahman A, Bonnet T, Ligot N, De Raedt S, Lemmens R, Vanacker P, Vandervorst F, Conforto AB, Hidalgo RCT, Mora Cuervo DL, de Oliveira Neves L, Lameirinhas da Silva I, Martíns RT, Rebello LC, Santiago IB, Sakelarova T, Kalpachki R, Alexiev F, Cora EA, Kelly ME, Peeling L, Pikula A, Chen HS, Chen Y, Yang S, Roje Bedekovic M, Čabal M, Tenora D, Fibrich P, Dušek P, Hlaváčová H, Hrabanovska E, Jurák L, Kadlčíková J, Karpowicz I, Klečka L, Kovář M, Neumann J, Paloušková H, Reiser M, Rohan V, Šimůnek L, Skoda O, Škorňa M, Šrámek M, Drenck N, Sobh K, Lesaine E, Sabben C, Reiner P, Rouanet F, Strbian D, Boskamp S, Mbroh J, Nagel S, Rosenkranz M, Poli S, Thomalla G, Karapanayiotides T, Koutroulou I, Kargiotis O, Palaiodimou L, Barrientos Guerra JD, Huded V, Nagendra S, Prajapati C, Sylaja PN, Sa… See abstract for full author list ➔ Nguyen TN, et al. J Stroke. 2022 May;24(2):256-265. doi: 10.5853/jos.2022.00752. Epub 2022 May 31. J Stroke. 2022. PMID: 35677980 Free PMC article.
  • Cerebral venous thrombosis.
    Moraes Junior AAA, Conforto AB. Moraes Junior AAA, et al. Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):53-59. doi: 10.1590/0004-282X-ANP-2022-S108. Arq Neuropsiquiatr. 2022. PMID: 35976298 Free PMC article. Review.
  • Neurovascular complications of antiphospholipid syndrome: a narrative review.
    Mendes GNN, Morais ABCG, Gioia LC, Jacquin G, Poppe AY, Soga FH, Andrade JBC. Mendes GNN, et al. Arq Neuropsiquiatr. 2024 Dec;82(12):1-7. doi: 10.1055/s-0044-1793932. Epub 2024 Dec 10. Arq Neuropsiquiatr. 2024. PMID: 39658037 Free PMC article. Review.

Publication types